Evidence map›Paper›PMID 41943556›Full record

ReviewAnnals of African medicine2026

Evaluating the Efficacy of Ozone Therapy in Fibromyalgia.

Prakhar Saxena, Satyalakshmi Komarraju, D Sathyanath, Shrikanth Muralidharan

Abstract readReview
In one paragraph

Review in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Prakhar SaxenaDepartment of Ozone, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, Maharashtra, India.
Satyalakshmi KomarrajuDepartment of Naturopathy and Yoga, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, Maharashtra, India.
D SathyanathDepartment of Natural Therapeutics, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, Maharashtra, India.
Shrikanth MuralidharanDepartment of Research, National Institute of Naturopathy, Ministry of Ayush, Government of India, Pune, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractFibromyalgia is a chronic disorder, characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and psychological distress, with limited efficacy from conventional treatments. Ozone therapy, a medical approach that induces controlled oxidative stress to enhance antioxidant defences and modulate immune responses, has emerged as a potential complementary intervention. Evidence suggests that ozone therapy improves pain, fatigue, and sleep quality by correcting oxidative imbalances, enhancing oxygen utilization, and regulating inflammatory pathways. Clinical studies, report significant symptom relief in up to 70% of patients, with minimal adverse effects when administered according to standardized protocols. Despite promising outcomes, the current literature is constrained by small sample sizes, heterogeneity in study designs, and limited long-term follow-up data. Future research should focus on large-scale, well-designed trials, standardized treatment protocols, and mechanistic studies to establish ozone therapy's role in fibromyalgia management.

Indexed as

FibromyalgiaOxidative StressOzoneAntioxidantsFatigueHumansTreatment OutcomeAntioxidantsOzoneAntioxidant defencechronic painDéfense antioxydantedouleur chroniquedu sommeilfibromyalgiafibromyalgieimmune modulationmédecine complémentairemodulation immunitaireoxidative stressozone therapyozonothérapiequalitéstress oxydatif

Identifiers

PMID41943556
PMCPMC13375089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.